Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF – Get Free Report)’s share price crossed above its 50 day moving average during trading on Wednesday. The stock has a 50 day moving average of $0.08 and traded as high as $0.0828. Sernova Biotherapeutics shares last traded at $0.0812, with a volume of 11,256 shares trading hands.
Sernova Biotherapeutics Stock Performance
The company’s 50-day moving average price is $0.08 and its 200 day moving average price is $0.10. The stock has a market cap of $30.66 million, a PE ratio of -2.03 and a beta of 0.90.
Sernova Biotherapeutics (OTCMKTS:SEOVF – Get Free Report) last posted its quarterly earnings data on Thursday, September 10th. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01).
Sernova Biotherapeutics Company Profile
Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies intended to treat chronic diseases by replacing or supplementing missing or dysfunctional cells. The company’s primary platform is the Cell Pouch System, an implantable device designed to create a vascularized environment that can house therapeutic cells and release biologically active substances into the body. Sernova has focused its research and development activities on cell-based treatments for conditions including insulin-dependent diabetes, hemophilia A and hypothyroidism.
Further Reading
- Five stocks we like better than Sernova Biotherapeutics
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Sernova Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
